Stéphan Vagner, PhD

VAGNER Janvier web

Stéphan Vagner Directeur d'unité Chef d'équipe Directeur de recherche INSERM Tél :

Publications clés

Année de publication : 2021

Lucilla Fabbri, Alina Chakraborty, Caroline Robert, Stéphan Vagner (2021 Sep 4)

The plasticity of mRNA translation during cancer progression and therapy resistance.

Nature reviews. Cancer : 558-577 : DOI : 10.1038/s41568-021-00380-y
Charlotte Audoynaud, Stéphan Vagner, Sarah Lambert (2021 Jul 5)

Non-homologous end-joining at challenged replication forks: an RNA connection?

Trends in genetics : TIG : DOI : S0168-9525(21)00166-9
Shensi Shen, Isabelle Girault, Hélène Malka-Mahieu, Caroline Robert, Stéphan Vagner (2021 Jun 23)

detection of the eIF4F translation initiation complex in mammalian cells and tissues.

STAR protocols : 100621 : DOI : 10.1016/j.xpro.2021.100621
Martin Dutertre, Rym Sfaxi, Stéphan Vagner (2021 Feb 27)

Reciprocal Links between Pre-messenger RNA 3′-End Processing and Genome Stability.

Trends in biochemical sciences : DOI : S0968-0004(21)00023-2
Gaetana Sessa, Belén Gómez-González, Sonia Silva, Carmen Pérez-Calero, Romane Beaurepere, Sonia Barroso, Sylvain Martineau, Charlotte Martin, Åsa Ehlén, Juan S Martínez, Bérangère Lombard, Damarys Loew, Stephan Vagner, Andrés Aguilera, Aura Carreira (2021 Feb 26)

BRCA2 promotes R-loop resolution by DDX5 helicase at DNA breaks to facilitate their repair by homologous recombination.

The EMBO journal : e106018 : DOI : 10.15252/embj.2020106018
Andrey Kleshnin, Léa Monet, Marina Plays, Hugo Vaysset, Claire Rougeulle, Stéphan Vagner (2021 Jan 6)

Amid darkness, light will prevail – a report on the 2020 annual SFC meeting on “Dark genome and Cancer”

Bulletin du cancer : DOI : S0007-4551(20)30510-5

Année de publication : 2018

Caroline Robert, Stéphan Vagner (2018 Nov 1)

Boosting Immunity by Targeting Post-translational Prenylation of Small GTPases.

Cell : 901-902 : DOI : S0092-8674(18)31385-0

Année de publication : 2017

Martin Dutertre, Stéphan Vagner (2017 Oct 27)

DNA-Damage response RNA-Binding Proteins (DDRBPs): Perspectives from a new class of proteins and their RNA targets.

Journal of molecular biology : DOI : 10.1016/j.jmb.2016.09.019
Michelle Newman, Rym Sfaxi, Abhijit Saha, David Monchaud, Marie-Paule Teulade-Fichou, Stéphan Vagner (2017 Oct 27)

The G-Quadruplex-Specific RNA Helicase DHX36 Regulates p53 Pre-mRNA 3′-End Processing Following UV-Induced DNA Damage.

Journal of Molecular Biology : 429 : 3121-3131 : DOI : 10.1016/j.jmb.2016.11.033
Helene Malka-Mahieu, Michelle Newman, Laurent Desaubry, Caroline Robert, Stephan Vagner (2017 Jan 1)

Molecular Pathways: The eIF4F Translation Initiation Complex- New Opportunities for Cancer Treatment.

Clinical cancer research : an official journal of the American Association for Cancer Research : DOI : 10.1158/1078-0432.CCR-14-2362

Année de publication : 2016

Anne Cammas, Magali Lacroix-Triki, Sandra Pierredon, Morgane Le Bras, Jason S Iacovoni, Marie-Paule Teulade-Fichou, Gilles Favre, Henri Roché, Thomas Filleron, Stefania Millevoi, Stéphan Vagner (2016 Mar 29)

hnRNP A1-mediated translational regulation of the G quadruplex-containing RON receptor tyrosine kinase mRNA linked to tumor progression.

Oncotarget : 7 : 16793-16805 : DOI : 10.18632/oncotarget.7589

Année de publication : 2014

Lise Boussemart, Hélène Malka-Mahieu, Isabelle Girault, Delphine Allard, Oskar Hemmingsson, Gorana Tomasic, Marina Thomas, Christine Basmadjian, Nigel Ribeiro, Frédéric Thuaud, Christina Mateus, Emilie Routier, Nyam Kamsu-Kom, Sandrine Agoussi, Alexander M Eggermont, Laurent Désaubry, Caroline Robert, Stéphan Vagner (2014 Sep 4)

eIF4F is a nexus of resistance to anti-BRAF and anti-MEK cancer therapies.

Nature : 105-9 : DOI : 10.1038/nature13572
Martin Dutertre, Sarah Lambert, Aura Carreira, Mounira Amor-Guéret, Stéphan Vagner (2014 Mar 1)

DNA damage: RNA-binding proteins protect from near and far.

Trends in biochemical sciences : 141-9 : DOI : 10.1016/j.tibs.2014.01.003

Année de publication : 2013

L Boussemart, E Routier, C Mateus, K Opletalova, G Sebille, N Kamsu-Kom, M Thomas, S Vagner, M Favre, G Tomasic, J Wechsler, L Lacroix, C Robert (2013 Jun 1)

Prospective study of cutaneous side-effects associated with the BRAF inhibitor vemurafenib: a study of 42 patients.

Annals of oncology : official journal of the European Society for Medical Oncology : 1691-7 : DOI : 10.1093/annonc/mdt015